PhD student of RUDN Medical Institute speaks at the V Congress of the Euro-Asian Society for Infectious Diseases
PhD student of RUDN Medical Institute speaks at the V Congress of the Euro-Asian Society for Infectious Diseases
May 16-18, 2018, V Congress of the Euro-Asian Society for Infectious Diseases in Novosibirsk brought together more than 400 doctors from Russian regions, as well as specialists from Kazakhstan, Uzbekistan, Kyrgyzstan and Belarus.

The event is aimed at sharing experience in the use of advanced medical technologies in the diagnosis, treatment and prevention of infectious diseases in adults and children, as well as in coordinating efforts to improve medical care for infectious patients.

Among the scientific directions of the Congress are biosafety, bacterial infections, viral infections, mycoses, tropical and parasitic diseases, hospital infections, immune disorders in infectious diseases, the problem of resistance of pathogens and rational antimicrobial chemotherapy, laboratory diagnostics,

Ekaterina Samotolkina, a PhD student of RUDN Department of Infectious Diseases with courses in epidemiology and phthisiology presented studies on the causes of death of severe HIV-infected patients in the intensive care unit, risk factors for cardiovascular disease in HIV-infected patients over the age of 40, analysis of the definition of insufficient adherence to treatment in the cascade of medical care for HIV-infected patients, and malaria situation on the territory of Ukraine. The materials are published in the Annex to the Journal "Infectology", indexed in Scopus.

The event was organized by the RF Ministry of Health, the Euro-Asian Society for Infectious Diseases, the Ministry of Health of the Novosibirsk Region, the Novosibirsk State Medical University, the Children's Scientific and Clinical Center for Infectious Diseases, St. Petersburg Public Organization "Humans and human health".

More information about the Congress http://ipoeasid.ru

News
All news
Science
06 Jul
A RUDN University chemist created anti-tumour compounds that are up to 80 times more effective than their counterparts

A chemist from RUDN University has created platinum complex compounds that are superior in activity to cisplatin, the drug for the treatment of tumour diseases. The new compounds turned out to be also less toxic to healthy cells.